Peter Higgs
Overview
Explore the profile of Peter Higgs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
1054
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Puvvada R, Marcucci J, Tang C, Thomas J, Higgs P, Madhan R, et al.
Health Expect
. 2025 Mar;
28(2):e70229.
PMID: 40088007
Background: The prevalence of type 2 diabetes (T2D) is rapidly increasing in India. Evidence suggests that adherence to both pharmacological and nonpharmacological treatment regimens combined with support from carers may...
2.
Broady T, Drysdale K, Brener L, Schroeder S, Marshall A, Lafferty L, et al.
Public Health
. 2025 Mar;
242:103-110.
PMID: 40054291
Objectives: Community attitudes contribute to social exclusion of people with incarceration and injecting drug use histories. Interventions that positively impact community attitudes can strengthen efforts to reduce recidivism and support...
3.
Stewart A, Hickman M, Agius P, Scott N, Stone J, Roxburgh A, et al.
BMJ Open
. 2025 Feb;
15(2):e091337.
PMID: 39933808
Background: Supervised injecting facilities (SIFs) are designed to reduce the harms associated with injecting drug use and improve access to health and support services for people who need them. The...
4.
Walker S, Rathnayake K, Dietze P, Higgs P, Ward B, Hellard M, et al.
Health Justice
. 2025 Jan;
13(1):6.
PMID: 39847147
Background: During the COVID-19 pandemic, governments worldwide introduced law enforcement measures to deter and punish breaches of emergency public health orders. For example, in Victoria, Australia, discretionary fines of A$1,652...
5.
Ong E, Xia T, Laing R, Richmond J, Higgs P, Hayes M, et al.
J Viral Hepat
. 2025 Jan;
32(2):e70001.
PMID: 39836067
The World Health Organisation (WHO) has set goals to eliminate hepatitis C (HCV) as a global health threat by 2030. To meet this goal, Australia must increase testing and diagnosis,...
6.
FitzGerald G, Cook J, Higgs P, Henderson C, Crawford S, Naren T
Med J Aust
. 2025 Jan;
222(4):164-167.
PMID: 39834001
No abstract available.
7.
Djordjevic F, Stewart A, Vella-Horne D, Gleeson Z, Pavlyshyn D, Gill M, et al.
BMJ Open
. 2025 Jan;
14(12):e091613.
PMID: 39806692
Introduction: Opioid overdose and blood-borne virus transmission are key health risks for people who inject drugs. Existing study methods that record data on injecting drug risks mostly rely on retrospective...
8.
Aung P, Hellard M, Dietze P, Petrovic B, Higgs P, Stoove M
Harm Reduct J
. 2024 Dec;
21(1):221.
PMID: 39707328
Background: We aimed to identify motivators for people who inject drugs to pursue treatment for hepatitis C virus (HCV) infection and uncover opportunities that could make treatment more appealing. Methods:...
9.
Treloar C, Baldry E, Higgs P, Dietze P, Stoove M, Lloyd A
Int J Prison Health
. 2024 Jul;
11(4).
PMID: 38987942
No abstract available.
10.
Doyle J, Heath K, Elsum I, Douglass C, Wade A, Kasza J, et al.
BMJ Open
. 2024 Jul;
14(7):e083502.
PMID: 38960465
Introduction: Despite universal access to government-funded direct-acting antivirals (DAAs) in 2016, the rate of hepatitis C treatment uptake in Australia has declined substantially. Most hepatitis C is related to injecting...